MDS Virtual Congress 2021 Archives - Page 71 of 132

D-penicillamine induced lupus erythematosus – the complication of Wilson’s disease treatment – a case report.

A. Antos, T. Litwin, A. Przybyłkowski, M. Skowrońska, I. Kurkowska-Jastrzębska, A. Członkowska (Warsaw, Poland)
Daily fluctuations of plasma ghrelin level in patients with different motor subtypes of Parkinson`s disease

K. Tarianyk, A. Shkodina (Poltava, Ukraine)
Dance for Movement Disorders: Improving Health and Quality of Life

K. Mason, D. Leventhal, J. Sonke, J. Langley, B. Whiteside, T. Gyang, B. Borgert, E. Johnson, D. Riley, C. Cassidy, L. Sinclair (Gainesville, USA)
Dance training and performance in patients with Parkinson disease: effects on motor functions and patients’ well-being.

O. Bouquiaux, A. Thibaut, C. Beaudart, G. Dorban (Fraiture-En-Condroz, Belgium)
DAT-IQ improves power to detect longitudinal change in DaT deficit in SURE-PD3

Z. Fan, J. Seibyl, K. Marek, M. Schwarzschild, E. Macklin, R. Gunn (London, United Kingdom)
DAT-SPECT in old onset Parkinson’s disease: should we trust?

G. Palermo, S. Giannoni, D. Frosini, U. Bonuccelli, R. Ceravolo (Pisa, Italy)
Data Driven Paths to Advancing Precision Medicine Strategies for Parkinson’s Disease: Critical Path for Parkinson’s Consortium

M. Muller, D. Dexter, J. Cosman, C. Zadikoff, S. Ali, N. Barwick, B. Bloem, B. Boroojerdi, J. Burton, C. Carroll, J. Cedarbaum, T. Dam, P. Dawkins, D. Grosset, N. Hanan, D. Hill, M. Hu, D. Jennings, S. Jones, K. Kieburtz, R. Lawson, K. Lee, K. Marek, H. Matthews, N. Mehrotra, J. Molinuevo, P. Muglia, A. Naito, G. Pagano, S. Sardi, M. Schwarzschild, A. Simen, T. Simuni, G. Stebbins, C. Venuto, C. Williams-Gray, D. Stephenson (Tucson, USA)
Data-driven model of dynamic biomarkers in SCA3 – from early pre-ataxic to late ataxic disease stages

J. Faber, T. Schaprian, C. Wilke, J. Huebener-Schmid, O. Riess, H. Garcia-Moreno, P. Giunti, B. Vande Warrenburg, J. van Gaalen, M. Lima, M. Raposo, L. Pereira, M. Santana, L. Schoels, J. de Vries, J. Infante, H. Jacobi, D. Timmann-Braun, K. Reetz, M. Schmid, T. Klockgether (Bonn, Germany)
Data-driven prediction of fatigue in Parkinson’s disease patients

DG. Lee, M. Mirian, L. Adrian, A. Yu, S. Neilson, K. Sundvick, E. Golz, L. Folger, S. Appel-Cresswell (Vancouver, Canada)
Data-driven Subtype Classification of Patients with Early-stage Multiple System Atrophy

HJ. Yang, YJ. Jung, HJ. Kim (Ulsan, Republic of Korea)
DBS Directional programming – Institution based study of programming in PD and ET patients

M. Moreno-Escobar, R. Elkins, S. Pallavaram, R. Tripathi (Morgantown, USA)
Decrease in STN high frequency activity after microelectrode insertion during DBS surgery for Parkinson’s disease

A. Clark, A. Izadi, J. Overton, K. O'Connor, G. Gurkoff, I. Saez, K. Shahlaie (Sacramento, USA)
Decreased expression of trace amines receptors on lymphocytes in Parkinson’s disease

Z. Muruzheva, I. Ivleva, V. Maystrenko, O. Tumashova, M. Karpenko (Saint-Petersburg, Russian Federation)
Decreased mesencephalic locomotor region activation explains loss of presynaptic inhibition during step initiation in people with Parkinson´s disease with freezing of gait

J. Lira, C. Ugrinowitsch, M. Nucci, D. Coelho, E. Barbosa, L. Teixeira, E. Júnior, F. Horak, M. Mancini, C. Batista (São Paulo, Brazil)
Deep brain stimulation (DBS) of the ventral-intermediate thalamic nucleus (VIM) compared to the posterior subthalamic area (PSA) for upper limb action tremor: A single-center, randomized, double-blind, crossover trial (Oslo Tremorstim study)

N. Kvernmo, A. Konglund, M. Reich, J. Roothans, A. Pripp, E. Dietrichs, J. Volkmann, IM. Skogseid (Oslo, Norway)
Deep Brain Stimulation for Dystonia: A Single-center Experience

S. Carr, T. Herrington, M. Supnet, X. Al Qahtani, P. Acuna, K. Kanoff, C. Wahle, N. Sharma, E. Penney (Charlestown, USA)
Deep brain stimulation for Orthostatic Tremor

W. Babeliowsky, W. Potter, M. Bot, P. Vanden Munckhof, P. Schuurman, E. Blok, R. de Bie, A. van Rootselaar (Amsterdam, Netherlands)
Deep brain stimulation for the management of tremor in a child with Rett syndrome

M. Hull, D. Curry, M. Parnes (Houston, USA)
Deep brain stimulation for tremor in chronic inflammatory demyelinating polyneuropathy: a series of three cases

G. Pallada, SEM. Ten Holter, F. Eftimov, SRM. Bus, D. van Poppelen, P. van Den Munckhof, M. Bot, RMA. de Bie, AF. van Rootselaar, JM. Dijk (Amsterdam, Netherlands)
Deep brain stimulation improves gait velocity acutely in patients with Parkinson’s disease

S. Miocinovic, L. Mckay, F. Isbaine, J. Nocera, J. Tran, S. Triche, C. Esper, P. Aia, L. Scorr, L. Higginbotham, C. Buetefisch (Atlanta, USA)
Deep Brain Stimulation in Confirmed Genetic Dystonias: A Comprehensive Review

H. Sarva, F. Rodriguez-Porcel, S. Barkan, E. Gatto, P. Garcia Ruiz (New York, USA)
Deep brain stimulation in Parkinson’s disease

S. Laassila, N. Chtaou (Fez, Morocco)
Deep Brain Stimulation of Anterior Globus Pallidus internus Reduces Impulsivity in Parkinson’s Disease

M. Kim, S. Baybayan, K. Moussawi, K. Mills (Baltimore, USA)
Deep brain stimulation of the pallidofugal pathways to rescue severe brittle dyskinesias after STN-DBS lead implantation

J. Avecillas Chasin, J. Jimenez-Shahed, J. Miravite, S. Bressman, B. Kopell (New York, USA)
DEEP BRAIN STIMULATION RESPONSE IN SIBLINGS WITH KMT2B DYSTONIA

E. Luque-Buzo, B. Casa Fages, J. Pérez Sáchez, M. González Sánchez, C. Fernández Carballal, JM. Garbizu Vidorreta, O. Sierra Mateo, A. Contreras Chicote, F. Grandas Pérez (Madrid, Spain)
Deep Brain Stimulation responsive Hemichorea-Hemiballism

S. Chandra, K. Block, M. Schiess (Houston, USA)
Deep Brain Stimulation Surgery and Clinical Characteristics of Essential Tremor in a Cohort of Veterans

F. Jamal, I. Noorbhai, G. Jackson, A. Sarwar (Houston, USA)
Deep gray matter atrophy in MSA subtypes

A. Campabadal, A. Abos, B. Segura, A. Perez-Soriano, D. Milena, E. Muñoz, Y. Compta, C. Junqué, M. Martí (Barcelona, Spain)
Deep learning based detection of Parkinson’s disease (PD) in Magnetic Resonance Imaging (MRI) brain scans

M. Courtman, L. Sun, E. Ifeachor, S. Mullin (Plymouth, United Kingdom)
Deficient interhemispheric connectivity underlies movement irregularities in Parkinson’s disease

M. Bange, G. Gonzalez-Escamilla, T. Marquardt, A. Radetz, C. Dresel, D. Herz, WI. Schöllhorn, S. Groppa, M. Muthuraman (Mainz, Germany)
Defining LRRK2-PD subsets based on olfactory function in the PPMI

K. Marek, A. Siderowf, C. Tanner, T. Simuni, L. Chahine, M. Brumm, C. Coffey (New Haven, USA)
Denoising Local Field Potentials from Electrocardiography Artifacts

C. Sannelli, E. Panken, G. Leogrande, S. Stanslaski (Maastricht, Netherlands)
Depression in Patients with Parkinson’s disease among Tomsk population

M. Nikitina, N. Alifirova, K. Nurzhanova, N. Zhukova (Tomsk, Russian Federation)
Design and Evaluation of the living lab to assess vCare system “virtual coaching activities for rehabilitation in elderly” in Parkinson´s disease patients

R. Del Pino, M. Diez-Cirarda, M. Caprino, S. Busnatu, V. Nitti, L. Pannese, A. Martínez, E. Sadner, J. Kropf, K. Gand, H. Schlieter, M. Vasile, P. Philipp, M. Lange, L. Nicolas, I. Gabilondo, JC. Gómez-Esteban (Barakaldo, Spain)
Detection of silent periods of muscle activity related to negative myoclonia

A. Sinokki, S. Rissanen, J. Hyppönen, K. Silvennoinen, L. Säisänen, P. Karjalainen, E. Mervaala, R. Kälviäinen (Kuopio, Finland)
Deterioration in oral health status potentially associated with apomorphine pump initiation: a case report

M. Auffret, V. Mathaut-Malefant, V. Denys, M. Tra, E. Boyer, V. Meuric, M. Bonnaure-Mallet, M. Vérin (Rennes, France)
Determinants of exercise behavior in Parkinson’s disease patients: Self-confidence in balance and fatigue play the pivotal role.

J. Song, WY. Shin, JH. Lim, JH. Ahn, I. Choi, J. Youn, JW. Cho (Seoul, Republic of Korea)
Determination of 5-HT3 receptor levels with [3H]-GR 65630 binding in hemi-parkinsonian rats with L-DOPA induced dyskinesia

C. Kwan, D. Bédard, I. Frouni, A. Hamadjida, P. Huot (Montreal, Canada)
Determination of the motor status after the implementation Levodopa-carbidopa intestinal gel in patients with advanced Parkinson’s disease using a Machine learning Algorithm

E. Efthymiopoulou, A. Antonoglou, B. Loupo, A. Bougea (Athens, Greece)
Determining the content of a clinician-rated tool for freezing of gait severity

A. Scully, B. de Oliveira, K. Hill, D. Tan, YH. Pua, R. Clark, E. Burton (Bentley, Australia)
Developing 31-phosphorus magnetic resonance spectroscopy (31P-MRS) as an imaging biomarker to identify mitochondrial dysfunction in Parkinson’s disease

T. Payne, M. Sassani, S. Roscoe, S. Bradley, A. Anton, E. Reed, I. Wilkinson, H. Mortiboys, T. Jenkins, O. Bandmann (Sheffield, United Kingdom)
Development of a remote physical exercise program during COVID-19 pandemic for individuals with Parkinson’s disease

C. Torriani-Pasin, T. Freitas, V. Domingues, B. Araújo, G. Palma, M. Makhoul, R. Andreotti, L. Mochizuki (Sao Paulo, Brazil)
Development of quantitative tools for in-home clinical assessment of people with Parkinson’s disease

T. Virmani, L. Pillai, A. Glover, A. Kemp, J. Utecht, H. Spencer, T. Nolan, M. Rutherford, P. Farmer, S. Syed, H. Eswaran, M. Lotia, J. Bona, L. Larson-Prior, F. Prior (Little Rock, USA)
Development of the CONSORTIUM FOR GLOBAL DIVERSITY IN PARKINSON’S DISEASE (CDG-PD) Patient Database

J. Bajwa, M. Salari, S. Khan, H. Amer, A. Al-Qassabi, A. Habib, J. Habib, M. Abu Al-Melh, M. Abu Snineh, Q. Un Nisa, S. Zaidi, A. Dahshan, W. Regragui, J. Ahmed, H. Shehata, I. Hashmat, N. Ullah Bullo, S. Om Mittal, T. Mohammad, W. Kamel, T. Houyam, S. Eljaffery, R. Rajan, M. Farghal, F. Abdulla, Z. Al-Daajani, P. Schmidt, H. Khalil (Riyadh, Saudi Arabia)
Development of the Huntington’s Disease Integrated Staging System (HD-ISS)

S. Tabrizi, S. Schobel, E. Gantman, A. Mansbach, B. Borowsky, P. Konstantinova, T. Mestre, A. Mullin, J. Panagoulias, K. Romero, C. Ross, S. Sivakumaran, E. Turner, M. Zauderer, J. Long, C. Sampaio (London, United Kingdom)
Development of the Parkinson’s Disease Medication Adherence Scale (PD-MAS)

M. Tosin, C. Goetz, G. Stebbins, B. Oliveira (Niteroi, Brazil)
Diabetes Mellitus in Huntington’s disease. The Argentinean perspective

N. Gonzalez Rojas, M. Cesarini, J. Etcheverry, E. Gatto (Buenos Aires, Argentina)
Diagnosis and management of Myoclonus Dystonia Syndrome: a Survey of the European Reference Network for Rare Neurological Diseases.

M. Vanegas, E. Timmers, F. Hamami, S. Boesch, W. Vandenberghe, O. Burgazlieva, M. Møller, L. Hjermind, M. Vidailhet, A. Meneret, T. Bäumer, S. Siegert, T. Gasser, L. Schoels, J. Molnar, A. Capuano, F. Nicita, G. Zorzi, A. Albanese, A. Federico, E. Lohmann, J. Guk, M. Willemsen, N. Wolf, M. Dec-Cwiek, D. Neubauer, D. Flisar, V. Gonzalez, A. Darling, M. Marti, H. Houlden, C. Reinhard, A. Weissbach, M. Tijssen, B. Perez-Dueñas (Barcelona, Spain)
Diagnostic accuracy in an incidence cohort of Parkinson’s disease

B. Brownlee, C. Counsell, A. Macleod (Aberdeen, United Kingdom)
Differential methylation signatures in Lewy body dementia

P. Reho, TG. Beach, GE. Serrano, KL. Newell, HP. Easwaran, JC. Troncoso, O. Pletnikova, SW. Scholz (Bethesda, USA)
Differentiating Gait Impairments in Early Parkinson’s Disease and Early Dementia with Lewy Bodies

K. Mathias, A. Pinto, E. Matar, J. Phillips, S. Lewis, K. Ehgoetz Martens (Waterloo, Canada)
Differentiation of Mild Cognitive Impairment (MCI) progression to Alzheimer Disease (AD) vs Dementia with Lewy Bodies (DLB): Is this possible neuropsychologically?

P. Voskou (Athens, Greece)
Difficulty with turning in bed in prediagnostic Parkinson’s disease

F. Dijkstra, V. Viaene, I. de Volder, P. Cras, D. Crosiers (Edegem, Belgium)
Digenic R1441G-LRRK2 and Parkin mutations in Parkinson’s Disease: first clinicopathological case report.

D. Campo-Caballero, A. Vinagre-Aragón, JF. Martí-Massó, A. Bergareche, A. Gorostidi, R. Ruiz-Onandi, J. Rodríguez-Antigüedad, J. Equiza, P. Iruzubieta-Agudo, I. Albajar, N. Sulibarria, J. Ruiz-Martinez (San Sebastián, Spain)
Direct Costs of patients with Parkinson’s Disease in a region of the Brazilian Amazon

R. Feio, T. França, A. Passos, A. Silva, A. Escudeiro, B. Koshimoto, D. Moura, B. Lobato (Belém, Brazil)
Directional deep brain stimulation causes distinct intraoperative LFPs in Parkinson’s patients

T. van Bogaert, J. Peeters, A. Boogers, P. de Vloo, B. Nuttin, M. Mc Laughlin (Leuven, Belgium)
Directional steering in subthalamic deep brain stimulation for Parkinson’s disease: the Berlin experience

V. Heinz, A. Marcelino, GH. Schneider, A. Kühn (Berlin, Germany)
Disease stage and nigrostriatal integrity predict motor progression in individuals with early Parkinson’s disease

H. Jackson, J. Anzures-Cabrera, K. Taylor, G. Pagano (Welwyn Garden City, United Kingdom)
Disentangling prodromal from non-prodromal symptoms of Parkinson’s disease

H. Jackson, J. Anzures-Cabrera, T. Simuni, R. Postuma, G. Pagano (Welwyn Garden City, United Kingdom)
Disparities in Access to Spasticity Chemodenervation Specialists in the United States: a National Analysis of Medicare Data

R. Kazerooni, S. Healy, M. Verduzco-Gutierrez (Raleigh, USA)
Dissociable contribution of serum NfL and p-tau181 to cognitive impairment and mild cognitive impairment in Parkinson’s disease.

J. Pagonabarraga, R. Pérez-González, H. Bejr-Kasem, A. Horta-Barba, I. Aracil-Bolaños, S. Martinez-Horta, E. Rivas-Asensio, J. Perez-Perez, F. Sampedro, A. Campolongo, C. Izquierdo, B. Pascual-Sedano, J. Kulisevsky (Barcelona, Spain)
Dissociated longitudinal evolution of limbic serotonergic and striatal dopaminergic and serotonergic pathology in apathetic and non-apathetic patients in early Parkinson’s disease

S. Prange, E. Metereau, H. Klinger, E. Schmitt, E. Lhommée, A. Bichon, D. Le Bars, A. Maillet, P. Pellissier, S. Meoni, E. Broussolle, A. Castrioto, P. Krack, S. Thobois (Bron, France)
Distinct cholinergic reactivity to dopamine is related with differed parkinsonian tremor responsiveness

J. Wu, C. Zhou, T. Guo, X. Guan, X. Bai, H. Wu, J. Chen, J. Wen, X. Liu, P. Huang, X. Xu, M. Zhang (Hangzhou, China)
Distinct impulsive traits in cerebellar ataxia and Parkinson’s disease

T. Chen, C. Lin, M. Aumann, D. Claassen, S. Kuo (New York, USA)
Distinct memory networks in Parkinson’s disease (PD) and Alzheimer’s disease (AD): Effects of APOE

G. Coughlan, P. Mclaughlin, K. Sunderland, M. Borrie, C. Fischer, A. Frank, M. Freedman, S. Kumar, S. Pasternak, B. Pollock, T. Rajji, D. Seitz, D. Tang-Wai, C. Tartaglia, J. Dewar, D. Kwan, B. Tan, D. Grimes, M. Jog, T. Lang, C. Marras, T. Steeves, D. Bulman, A. Dilliott, M. Ghani, R. Hegele, J. Robinson, E. Rogaeva, S. Farhan, R. Bartha, N. Nanayakkara, J. Ramirez, C. Scott, S. Symons, C. Berezuk, M. Holmes, S. Adamo, M. Ozzoude, A. Theyers, S. Arnott, D. Beaton, W. Lou, S. Sujanthan, B. Levine, J. Orange, A. Peltsch, A. Roberts, A. Troyer, M. Binns, S. Black, S. Strother, M. Moscovitch, C. Grady, M. Masellis (Toronto, Canada)
Distinct oscillatory fingerprints in dyskinesias mediated by D1 versus D2 receptors

K. Skovgård, P. Halje, SA. Barrientos, P. Petersson, MA. Cenci (Lund, Sweden)
Distinct patterns of dyskinetic and dystonic features following D1 or D2 receptor stimulation in a mouse model of parkinsonism

L. Andreoli, M. Abbaszadeh, X. Cao, A. Cenci Nilsson (Lund, Sweden)
DNA methylation of CDKN2B/CDKN2B-AS1 enhancer in Huntington’s disease and lung cancer

I. Goncharova, E. Bragina, D. Gomboeva, N. Babushkina, A. Markov, M. Nazarenko, M. Nikitina, V. Alifirova, N. Zhukova, S. Illarioshkin, V. Puzyrev (Tomsk, Russian Federation)
DNMSQuest: a simple tool for identifying mood disorders in cervical dystonia?

S. Rafee, S. O'Riordan, M. Hutchinson (Dublin, Ireland)
DO FREEZING OF GAIT AND GAIT AUTOMATICITY IN PARKINSON’S DISEASE SHARE THE SIMILAR NEURAL SUBSTRATE?

F. de Almeida, C. Ugrinowitsch, M. Nucci, D. Coelho, A. Moreira-Neto, E. Barbosa, L. Teixeira, E. Amaro JR., F. Horak, M. Mancini, C. Silva-Batista (São Paulo, Brazil)
Do Parkinson’s disease medications have an effect on gut microbiome? A case-control study

P. Zhang, P. Huang, Y. Qian, X. Yang, Y. He, J. Du, G. Li, S. Cui, S. Xu, J. Liu, Y. Lin, Y. Fu, G. He, Z. Zhang, Q. Xiao, S. Chen (Shanghai, China)
Does cognition, depression and quality of life influence the balance of elderly with Parkinson’s disease ?.

L. Pereira, P. Broto, M. Terra, N. Barboza, H. Oliveira Araújo, M. Bueno, S. Smaili (Londrina, Brazil)
Does Macronutrient dietary Intake of patients with Parkinson disease correlates with the cognitive function (MoCA)?

C. López Botello, S. Castillo Torres, I. Estrada Bellmann, B. Chávez Luevanos (Monterrey, Mexico)
Does MDS-UPDRS provide greater sensitivity to mild disease than UPDRS for assessing motor severity in early Parkinson’s disease?

D. Hall, M. Tosin, C. Patterson, G. Stebbins (Chicago, USA)
Does Microneedle Use for Facial Injection of Botulinum Toxin Reduce Pain? A Systematic Literature Review

S. Maytharakcheep (Bangkok, Thailand)
Does neurodegeneration of the noradrenergic locus coeruleus follow a spatial gradient in Parkinson’s disease?

C. Madelung, D. Meder, S. Fuglsang, V. Boer, E. Petersen, A. Løkkegaard, H. Siebner (Hvidovre, Denmark)
Does the observation of an action inserted in an emotion-enriched context influence cortical excitability in patients with Parkinson’s disease?

G. Lagravinese, E. Pelosin, A. Bisio, G. Bonassi, M. Putzolu, A. Botta, C. Cosentino, C. Ponte, S. Mezzarobba, L. Avanzino (Genoa, Italy)
Dopamine dysregulation syndrome in Parkinson’s disease after COVID-19. Case report.

A. Nikitina, D. Degterev (Moscow, Russian Federation)
DOPAMINERGIC AND NON-DOPAMINERGIC TREATMENT AFTER DEEP BRAIN STIMULATION (DBS) IN PARKINSON DISEASE (PD). IMPORTANCE OF NON MOTOR SYMPTOMS (NMS)

T. Muñoz Ruiz, L. García Trujillo, G. Pons Pons, L. Romero Moreno, M. Troya Castilla, V. Fernández Sánchez, P. Serrano Castro (Málaga, Spain)
Double labeling alpha-synuclein in labial minor salivary glands in Parkinson’s disease and idiopathic RBD patients

G. Mangone, M. Houot, S. Boluda Casas, A. Chalancon, A. Prigent, D. Seilhean, JC. Corvol, M. Vidailhet, C. Duyckaerts, B. Degos (Paris, France)
Dream enactment behavior disorder associated with pallido-nigro-luysian degeneration and tau proteinopathy

D. Di Luca, E. Slow, I. Martinez-Valbuena, A. Lang, G. Kovacs (Toronto, Canada)
Dual task training: knowledge, experiences and educational needs of Healthcare and exercise providers in Parkinson’s disease

J. Domingos, K. śmiłowska, J. Dean, C. Godinho (Nijmegen, Netherlands)
Dual-task interference on weight-shifting in Parkinson’s Disease with freezing of gait and without freezing of gait

YT. Hung, CY. Tsai, RM. Wu, CY. Huang (Taipei, Taiwan)
Dynamic functional connectivity changes in Parkinson’s disease patients with REM sleep behavior disorder

C. Gan, K. Zhang, Y. Yuan (Nanjing, China)
Dysautonomia and cognitive impairment in Essential Tremor: is there a link?

A. Rekik, A. Nasri, S. Mrabet, M. Bendjebara, A. Gargouri, I. Kacem, R. Gouider (Manouba, Tunisia)
Dysfunctional resting connectivity in early stage of Parkinson’s disease is indistinguishable from connectivity in REM sleep behaviour disorder

P. štofaniková, F. Růžička, K. Mueller, T. Ballarini, E. Růžička, K. šonka, P. Dušek, R. Jech (Prague, Czech Republic)
Dyskinesia, Pain, and Quality of Life in Parkinson’s Disease: Post Hoc Analysis From the DYSCOVER Study

E. Freire Alvarez, P. Vanni, E. Kurca, L. Lopez Manzanares, N. Kovacs, C. Spanaki, Y. Liu, T. Gao, L. Bergmann, O. Sanchez-Solino, L. Barbato (Elche, Alicante, Spain)
Dysphagia in Hispanic patients with Parkinson’s disease – A single center 5-year retrospective chart review study

E. Wang, F. Camarena, S. Schott (Chicago, USA)
Dysphagia risk, respiratory muscle strength and maximal phonation time in elderly with Parkinson Disease in the initial stages

R. Gonçalves, T. de Freitas, N. de Souza, J. Veras, J. Barbosa Neto, C. Araújo, C. Do Amaral, D. Dalles, L. Cardoso, P. Cortez, E. Andrade, M. Cardoso (Manaus, Brazil)
Dystonia due to GM3 synthase deficiency

A. Wang, C. Kilbane (South Euclid, USA)
Dystonia gravidarum: An emerging clinical entity

E. Donlon, P. Moloney, S. Smyth, S. Lyons, T. Lynch, E. Mcgovern (Limerick, Ireland)
Dystonic Posturing with Athetoid Movements in Stroke Without Thalamic Lesion

A. Ferreira, V. Carvalho, P. Simões Coelho (Porto, Portugal)
Dystonic tremor and ataxia as presenting symptoms of multiple sclerosis

S. Healy, V. Bharambe, D. Damodaran (Liverpool, United Kingdom)